CHOP Orthopedics Leadership Transition Signals Focus on Hip Disorder Innovation

  • Wudbhav N. Sankar, MD, will become Chief of CHOP’s Orthopedic Center, effective July 1, 2026.
  • John M. Flynn, MD, is stepping down as Chief after 30 years at CHOP and over a decade as Chief of Orthopedics.
  • Dr. Sankar, currently Director of the Young Adult Hip Preservation Program and Hip Disorders Program at CHOP, has pioneered several innovative treatments.
  • Dr. Flynn’s tenure saw advancements including faster scoliosis surgery, limb-sparing tumor treatments, and reduced postoperative narcotic use.

The leadership change at CHOP’s Orthopedic Center highlights the ongoing need for innovation and specialized care in pediatric orthopedics, a field increasingly driven by technological advancements and patient-centered approaches. The emphasis on hip disorder expertise suggests a strategic focus on a complex and growing area of need, positioning CHOP to capture a larger share of referrals. The transition also underscores the importance of succession planning within leading healthcare institutions to ensure continuity of care and maintain a competitive advantage.

Innovation Focus
Dr. Sankar’s appointment signals a continued emphasis on innovation, particularly in hip disorder treatments, which could attract further research funding and patient referrals.
Succession Risk
The transition from a long-tenured leader like Dr. Flynn to an internal successor carries the risk of disruption to established programs and potential loss of institutional knowledge.
Competitive Landscape
CHOP’s continued ranking among the nation’s top pediatric hospitals necessitates ongoing investment in talent and technology to maintain its competitive edge against other leading institutions.